Sponsorluk
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Posted
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Site içinde arama yapın
Kategoriler
- National
- International
- Business
- Technology
- Health
- EĞİTİM BİLGİLERİ
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Russia oil trouble hits: Shipowners and oil traders avoiding Russia-backed Nayara Energy in India; impact after EU sanctions
Global shipping firms and petroleum traders are reportedly avoiding Nayara Energy, an Indian...
Gagan Thapa rules out future electoral alliances for Nepali Congress
CHITWAN: Nepali Congress General Secretary Gagan Kumar Thapa has stated that the party has...